Vedolizumab as Induction and Maintenance Therapy for Crohn's DiseaseWilliam J. Sandborn, Asit Parikh, Scott Lee et al.|New England Journal of Medicine|2013Cited by 2.7k
Risk Assessment and Minimization for Progressive Multifocal Leukoencephalopathy (PML RAMP): A Program to Assess for Potential Early Signs and Symptoms of PML during Clinical Development of VedolizumabDavid Clifford, Asit Parikh, Megan McAuliffe et al.|The American Journal of Gastroenterology|2013Cited by 8
A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical TrialsAsit Parikh, David B. Clifford, Kristin Stephens et al.|Drug Safety|2018Cited by 6
Vedolizumab Maintenance Therapy for Crohnʼs Disease: Results of GEMINI II, a Randomized, Placebo-Controlled, Double-Blind, Multi-center Phase 3 TrialStephen B. Hanauer, Asit Parikh, Jean–Frédéric Colombel et al.|The American Journal of Gastroenterology|2012Cited by 5